Dentsply Sirona renews its Symbios Allograft product line with a focus on the highest level of sterility and versatility

Regenerative Solutions

The Symbios® Allograft line consists of a diverse range of products spanning different clinical applications, including Granule bone grafts, Putty bone grafts and Acellular Dermal Matrix. The enhanced range is now available in the USA and Canada.

Charlotte, N.C., July 22, 2024. Dentsply Sirona is committed to deliver solutions that advance dentistry for the best patient outcomes and empower dental professionals. The newly enhanced Symbios® Allograft mineralized and demineralized line of regenerative solutions is designed for wide range of dental surgery and implant needs – helping promote bone formation, volume, and stability for predictable, long-term outcomes. The updated portfolio includes new granule allografts, putty products, and acellular dermal matrix, Symbios PerioDerm®.
“The updates to our Symbios® Allograft portfolio was introduced with the needs of both clinicians and patients in mind, offering predictable handling every step of the way,” said Tony Susino, GVP Implant & Prosthetic Solutions at Dentsply Sirona. “Our enhanced range is a testament to scientific rigor, continuing our legacy of excellence in precision and sterility to deliver fast and accurate results that both clinicians and patients can rely on.”
Advance regenerative practices with confidence - excellence in safety, sterility, and precision
The Symbios® Allograft range now features a wide range of mineralized and demineralized granules and mixtures of both, with a newly selected granule size for enhanced performance and versatility. The allografts adhere to the strictest standards of donor screening, disinfection, cleaning, preservation, and inspection, with minimal manipulation to preserve tissue integrity.
“I have been utilizing the new Symbios Allograft bone graft granule portfolio for some time now. The size and texture of the granules allowed them to mix well with blood concentrate materials at the time of placement, resulting in good handling properties. The most satisfying part is the uncovering, seeing less particles always gives me comfort knowing we were able to develop vital bone,” said Dr. Sausha Toghranegar, periodontist.
Collaborations with two trusted companies to develop the new granule, dermis, and putty products
Dentsply Sirona works with RegenX for the granule portfolio that utilizes the patented Excellion® process for bone processing procedures, offering mineralized and demineralized cortical and cancellous granules and a mixture of both. The granules are designed for a wide range of regenerative applications, offering enhanced performance and versatility.
Dentsply Sirona has also continued its long-term relationship with MTF Biologics® to deliver dermis and putty products. DBX® Putty offers a prefilled, ready-to-use syringe of demineralized bone putty, while the PerioDerm® Acellular Dermis soft tissue graft is processed to preserve its extracellular matrix while removing cellular components.

Both companies are accredited by the American Association of Tissue Banks and registered with the FDA. In addition, they provide donated tissues that undergo rigorous donor screening criteria, with less than 2% of donations accepted. *
For more information about Symbios® Allograft, visit Symbios: Bone & Tissue Regeneration | Dentsply Sirona USA

* Reference – Data on file